No matter how cynical the overall market is Atricure Inc (ATRC) performance over the last week is recorded -8.26%

Atricure Inc (NASDAQ: ATRC) kicked off on Friday, down -4.82% from the previous trading day, before settling in for the closing price of $25.31. Over the past 52 weeks, ATRC has traded in a range of $25.20-$59.61.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 15.61% over the past five years. While this was happening, its average annual earnings per share was recorded -10.37%. With a float of $46.71 million, this company’s outstanding shares have now reached $47.53 million.

Let’s look at the performance matrix of the company that is accounted for 1200 employees.

Atricure Inc (ATRC) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Atricure Inc is 3.45%, while institutional ownership is 97.89%. The most recent insider transaction that took place on Apr 01 ’24, was worth 45,585. In this transaction Chief Mktg & Strategy Officer of this company sold 1,500 shares at a rate of $30.39, taking the stock ownership to the 72,784 shares. Before that another transaction happened on Mar 18 ’24, when Company’s Chief Legal Officer sold 1,885 for $32.16, making the entire transaction worth $60,622. This insider now owns 50,954 shares in total.

Atricure Inc (ATRC) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of 17.01 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -10.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to -1.17% drop over the previous five years of trading.

Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators

Take a look at Atricure Inc’s (ATRC) current performance indicators. Last quarter, stock had a quick ratio of 2.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.92.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.58 in one year’s time.

Technical Analysis of Atricure Inc (ATRC)

Atricure Inc (NASDAQ: ATRC) saw its 5-day average volume 0.73 million, a positive change from its year-to-date volume of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 4.04%. Additionally, its Average True Range was 1.36.

During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 1.97%, which indicates a significant decrease from 5.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.95% in the past 14 days, which was higher than the 47.23% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $31.88, while its 200-day Moving Average is $39.36. Nevertheless, the first resistance level for the watch stands at $24.80 in the near term. At $25.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $26.06. If the price goes on to break the first support level at $23.54, it is likely to go to the next support level at $23.00. Assuming the price breaks the second support level, the third support level stands at $22.28.

Atricure Inc (NASDAQ: ATRC) Key Stats

The company with the Market Capitalisation of 1.17 billion has total of 48,375K Shares Outstanding. Its annual sales at the moment are 399,250 K in contrast with the sum of -30,440 K annual income. Company’s last quarter sales were recorded 106,540 K and last quarter income was -9,790 K.